Model Lottie Moss Warns of Ozempic Dangers After Hospitalization

Lottie Moss, sister of renowned supermodel Kate Moss, has issued a stark warning about the dangers of using Ozempic for weight loss. The 26-year-old model recently shared her harrowing experience with the diabetes medication, which led to her hospitalization.

Ozempic, a brand name for semaglutide, was initially approved by the FDA in 2017 for treating type 2 diabetes. However, its off-label use for weight loss has gained popularity, raising concerns among health professionals.

Moss revealed that she obtained the drug through unofficial channels, bypassing proper medical supervision. She admitted to taking doses intended for individuals weighing over 100 kilograms, despite her own weight being in the 50-60 kilogram range. This misuse resulted in severe side effects, including extreme nausea, rapid weight loss, and dangerous dehydration.

"Please, if you're thinking of taking it, do not take it, it's so not worth it."

The model's ordeal culminated in a frightening episode where she experienced a seizure due to severe dehydration. This incident led to her being rushed to the emergency room, where medical professionals expressed shock at the high dosage she had been taking.

Moss's experience highlights the risks associated with using prescription medications without proper medical guidance. Ozempic's common side effects include nausea, vomiting, and abdominal pain, which can be exacerbated when taken incorrectly.

The model's cautionary tale comes amid growing concerns about unhealthy body image trends in the fashion industry. Moss criticized the resurgence of the "heroin chic" look, popularized in the 1990s and associated with her sister Kate Moss. She expressed disappointment in the apparent retreat from body positivity movements, questioning, "Where did the body positivity go?"

This incident has reignited discussions about the fashion industry's impact on body image and the dangers of extreme weight loss methods. It serves as a reminder of the importance of promoting healthy body standards and seeking professional medical advice before using any weight loss medications.

In the UK, Ozempic is currently only available through the NHS for patients with type 2 diabetes or specific obesity-related conditions, underscoring the need for careful regulation of such powerful medications.

As the debate around body image and weight loss continues, Lottie Moss's story serves as a powerful warning about the potential consequences of prioritizing rapid weight loss over health and well-being.